BlackRock’s PHARMACYCLICS INC PCYC Stock Holding History

BlackRock’s Portfolio PCYC Stock Details PCYC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-51,521	Closed	-$13.2M	–	3345
2015 Q1	$13.2M	Buy	51,521 +5,809	+13%	+$1.12M	0.02%	621
2014 Q4	$5.59M	Buy	45,712 +2,616	+6%	+$334K	0.01%	801
2014 Q3	$5.06M	Sell	43,096 -1,027	-2%	-$117K	0.01%	814
2014 Q2	$3.96M	Sell	44,123 -29,796	-40%	-$2.8M	0.01%	894
2014 Q1	$7.41M	Buy	73,919 +41,779	+130%	+$5.43M	0.01%	736
2013 Q4	$3.4M	Buy	32,140 +26,754	+497%	+$3.25M	0.01%	911
2013 Q3	$744K	Buy	5,386 +2,121	+65%	+$235K	﹤0.01%	1151
2013 Q2	$259K	Buy	+3,265	New	+$267K	﹤0.01%	1424

Other funds holding PCYC

Credit Agricole Montrouge Cedex, France $38.1B AUM

BlackRock's PCYC Position: Q2 2015 in Review

BlackRock sold out of PHARMACYCLICS INC (PCYC) in Q2 2015, closing a stake of 51,521 shares — an estimated $13.2M sold.

BlackRock first reported a position in PCYC in Q2 2013 and held it in 8 quarters. The position peaked at $13.2M in Q1 2015. 1 fund tracked by Wall St. Rank holds PCYC as of Q2 2015.

BlackRock reported no remaining PHARMACYCLICS INC position as of Q2 2015 after selling out during the quarter.
BlackRock sold 51,521 PHARMACYCLICS INC shares in Q2 2015, an estimated $13.2M.
BlackRock first reported a position in PHARMACYCLICS INC in Q2 2013 and held it in 8 quarters.
BlackRock's PHARMACYCLICS INC position peaked at $13.2M in Q1 2015.
1 fund tracked by Wall St. Rank held PHARMACYCLICS INC as of Q2 2015.

Based on BlackRock's 13F filing for Q2 2015, filed 7 Aug 2015.